Cargando…
The Efficacy of MDMA (3,4-Methylenedioxymethamphetamine) for Post-traumatic Stress Disorder in Humans: A Systematic Review and Meta-Analysis
Background: 3,4-methylenedioxymethamphetamine (MDMA), known recreationally as “Molly” or “Ecstasy”, is a triple monoamine reuptake inhibitor. MDMA specifically acts as a weak 5-HT1 and 5-HT2 receptor agonist, targeting 5-HT(2A), 5-HT(2B), and 5-HT(2C )receptors. Its potential use for therapeutic pur...
Autores principales: | Tedesco, Sarah, Gajaram, Ganeya, Chida, Shahzad, Ahmad, Arham, Pentak, Meghan, Kelada, Marina, Lewis, Layth, Krishnan, Deepa, Tran, Carolyn, Soetan, Oladipo T, Mukona, Lawrance T, Jolayemi, Ayodeji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207489/ https://www.ncbi.nlm.nih.gov/pubmed/34150406 http://dx.doi.org/10.7759/cureus.15070 |
Ejemplares similares
-
3,4-methylenedioxymethamphetamine (MDMA): current perspectives
por: Meyer, Jerrold S
Publicado: (2013) -
Effects of (±) 3,4-Methylenedioxymethamphetamine (MDMA) on Sleep and Circadian Rhythms
por: McCann, Una D., et al.
Publicado: (2007) -
A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
por: Sessa, Ben, et al.
Publicado: (2019) -
Autoscopic Hallucinations in an African American Female Patient With Schizophrenia
por: Gajaram, Ganeya, et al.
Publicado: (2021) -
A review on the mitochondrial toxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA)
por: Capela, João Paulo, et al.
Publicado: (2022)